2022 American Transplant Congress » Immunosuppression & Tolerance: Preclinical & Translational Studies
Date: Monday, June 6, 2022
Time: 7:00pm-8:00pm
Location: Hynes Halls C & D
Session Type: Poster Abstract
Meeting: 2022 American Transplant Congress
- 7:00pm-8:00pm
A Novel Immunosuppressive Compound (79-6) That Targets Bcl6 Prevents the Humoral Alloresponse
- 7:00pm-8:00pm
Apheresis of Deceased Donors: A New Source of Mobilized Peripheral Blood Hematopoietic Stem Cells for Transplant Tolerance
- 7:00pm-8:00pm
Belatacept Augments Mixed Chimerism in a Novel Nonhuman Primate Kidney Transplant Tolerance Induction Protocol
- 7:00pm-8:00pm
Evs from Patients with Amr Induce Tubular Senescence and Endmt Through Horizontal Transfer of Mirnas
- 7:00pm-8:00pm
Gene Profiling to Distinguish Mechanisms of Liver Allograft Rejection and Acceptance in Cynomolgus Monkey
- 7:00pm-8:00pm
Il-33 Induced Regulatory Macrophages Inhibit Transplantation Immune Rejection by Inducing Tregs
- 7:00pm-8:00pm
Immunomodulatory Effects of Probiotic Bifidobacterium Bifidum with Tacrolimus and Sirolimus in Mouse Skin Graft Model
- 7:00pm-8:00pm
Immunosuppressants Alter Lymph Node Architecture and Create Distinct Microbiome Footprints
- 7:00pm-8:00pm
Impact of Changing Tacrolimus Formulation on Cerebral Blood Flow and Cognitive Function
- 7:00pm-8:00pm
NecroX-7 Ameliorate FK506-Induced Nephrotoxicity in LLC-PK1 Cells (Pig Kidney Epithelial Cells)
- 7:00pm-8:00pm
PD-1 Expression on CD8+ T Cells Contributes to the Establishment of Mixed Chimerism-Based Operational Tolerance
« View all sessions from the 2022 American Transplant Congress